2025 PACC Miami | Isatuximab Subcutaneous by On-Body Injector vs. Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed Refractory Multiple Myeloma
0% Complete
Course Content
Credits
- AMA PRA Category 1 Credit™Non-CME
Course Details
- Duration
- 0.00 hour
- Released
- Nov 23, 2025
- Last Review
- Nov 23, 2025
- Expires
- Nov 23, 2026
Target Audience
Pharmacists
Faculty & Disclosure
Faculty
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE
Accreditation
NA
Related Courses
2026 SPS Twin Cities | Hyaluronidase Delivering New Subcutaneous Dosage Forms Throughout Various Therapeutic Areas: A Dive into Clinical, Safety, Practice and Economic Considerations
0.00 Credits
1 Chapter
Pharmacology
Free
2026 SPS Twin Cities | CMS Drug Price Negotiations Through Maximum Fair Price (MFP): Access & Practice Considerations Now & Then
0.00 Credits
1 Chapter
Pharmacology
Free